Citadel Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Citadel Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,500	Closed	-$19K	–	8816
2015 Q4	$19K	Sell	2,500 -1,900	-43%	-$14.5K	﹤0.01%	7987
2015 Q3	$31K	Hold	4,400	–	–	﹤0.01%	7906
2015 Q2	$47K	Buy	4,400 +2,400	+120%	+$28.1K	﹤0.01%	7693
2015 Q1	$25K	Buy	+2,000	New	+$22.1K	﹤0.01%	7781
2014 Q1	–	Sell	-1,900	Closed	-$23K	–	8155
2013 Q4	$23K	Buy	1,900 +1,500	+375%	+$15.6K	﹤0.01%	6398
2013 Q3	$3K	Buy	+400	New	+$3.45K	﹤0.01%	6637

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Citadel Advisors's ELOS Position: Q2 2017 in Review

Citadel Advisors sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 11,835 shares — an estimated $130K sold.

Citadel Advisors first reported a position in ELOS in Q2 2013 and held it in 12 quarters. The position peaked at $2.28M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Citadel Advisors reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Citadel Advisors sold 11,835 Syneron Medical Ltd shares in Q2 2017, an estimated $130K.
Citadel Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 12 quarters.
Citadel Advisors's Syneron Medical Ltd position peaked at $2.28M in Q1 2015.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.